Nutex Health, Inc. (NASDAQ: NUTX) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
Nutex Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $172.01, Nutex Health, Inc. trades at 7.3x trailing earnings, 1.5x sales and 2.7x book value, with an EV/EBITDA of 3.9. Over the last twelve months it generated about $791M of revenue and $162M of net income. It runs a gross margin of 47.8%, an operating margin of 39.0% and a net margin of 20.7%. It shows return on equity of 43.8%, return on invested capital of 27.1% and a free cash flow yield of 21.1%. On the balance sheet: a debt-to-equity ratio of 0.84 and a current ratio of 4.76. Over the past 52 weeks the share price ranged from $83.99 to $226.16, with a beta of 2.00.
Nutex Health, Inc. does not currently pay a dividend.
5 Wall Street analyst ratings cover the stock: 5 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Nutex Health, Inc. (NUTX) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 3.11% / 30% · (Cash+Inv) / Mkt Cap (36m) 18.3% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 3.11% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 18.3% / 33% · Receivables / Mkt Cap (36m) 26.5% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 3.11% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 18.3% / 33.33% · Receivables / Mkt Cap (24m) 26.5% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 4.30% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 21.9% / 33.33% · Receivables / Avg Assets (4Q) 35.7% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 4.10% / 33.33% · (Cash+ST Inv) / Total Assets 24.2% / 33.33% · (Cash+Recv) / Total Assets 59.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Nutex Health, Inc. (NUTX) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Nutex Health, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Nutex Health, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.